Independent directory Public ClinicalTrials.gov records United States
Location Directory

Clinical trials in New York, New York

This page shows live ClinicalTrials.gov search results for New York, New York, with direct links to official study records plus on-page filtering and sorting for broad location searches.

ClinicalTrials.gov public records Last synced Sep 15, 2026, 7:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials
5934
Shown on this page
12
Local exact-city summaries
5934
Based on exact city/state matches in the local index.
Local exact-city recruiting
3225
Live official results below use the broader ClinicalTrials.gov location search.
The trial list below is retrieved from the live ClinicalTrials.gov search API for New York, New York. Results on this page are currently sorted by Recently updated. Use the filter controls below to narrow by condition, treatment, sponsor, recruitment status, phase, study type, sex, or age.

Filter and sort this location

These controls apply only within New York, New York. Default order is Recently updated. Use recruitment status if you want to focus on actively recruiting studies in this location.

Reset location filters
Clear filters
Showing 1–12 of 5,934 matching trials in New York, NY.
Indexed local directory records.
The summary panels and records below use exact city/state matches from the local directory for New York, NY. Use the filters or full search link when you want broader live ClinicalTrials.gov location matching.

Indexed official records

Open in full search
Conditions
Amyotrophic Lateral Sclerosis
Interventions
Placebo, Pridopidine
Drug
Lead sponsor
Prilenia
Industry
Eligibility
18 Years to 80 Years
Enrollment
500 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2029
U.S. locations
18
States / cities
Phoenix, Arizona • San Francisco, California • Aurora, Colorado + 14 more
Conditions
Mantle Cell Lymphoma, B Cell Lymphoma
Interventions
Sonrotoclax, Zanubrutinib, Placebo
Lead sponsor
BeOne Medicines
Industry
Eligibility
18 Years and older
Enrollment
300 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2032
U.S. locations
41
States / cities
Birmingham, Alabama • Tucson, Arizona • Fresno, California + 34 more
Recruiting Not applicable Interventional Accepts healthy volunteers

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

NCT05977751
Conditions
Contraception
Interventions
FemBloc
Device
Lead sponsor
Femasys Inc.
Industry
Eligibility
21 Years to 50 Years · Female only
Enrollment
573 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023 – 2031
U.S. locations
10
States / cities
Chandler, Arizona • Palo Alto, California • Sacramento, California + 7 more
Conditions
Advanced Solid Tumors
Interventions
5-fluorouracil, Calderasib, Pembrolizumab, carboplatin, cetuximab, leucovorin, oxaliplatin, pemetrexed
Drug · Biological
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Eligibility
18 Years and older
Enrollment
830 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2030
U.S. locations
6
States / cities
Tampa, Florida • Grand Rapids, Michigan • Hackensack, New Jersey + 3 more
Conditions
Tricuspid Regurgitation, Tricuspid Valve Disease, Tricuspid Valve Insufficiency
Interventions
Edwards PASCAL System, Optimal Medical Therapy
Device · Drug
Lead sponsor
Edwards Lifesciences
Industry
Eligibility
18 Years and older
Enrollment
1,270 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2031
U.S. locations
73
States / cities
Phoenix, Arizona • Tucson, Arizona • Irvine, California + 59 more
Conditions
Food Insecurity, Healthy Eating
Interventions
Delivery fee waiver, Financial incentive, Grocery list with instant shoppable SNAP-Ed recipes, Texting, Video tutorial
Behavioral
Lead sponsor
New York University
Other
Eligibility
2 Years and older
Enrollment
360 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2029
U.S. locations
1
States / cities
New York, New York
Conditions
Secondary Immune Deficiency
Interventions
IgPro20
Biological
Lead sponsor
CSL Behring
Industry
Eligibility
18 Years and older
Enrollment
63 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2029
U.S. locations
17
States / cities
Orange, California • Denver, Colorado • Coral Springs, Florida + 14 more
Conditions
Advanced Breast Cancer, Early Breast Cancer
Interventions
ZOLADEX
Drug
Lead sponsor
TerSera Therapeutics LLC
Industry
Eligibility
18 Years to 55 Years · Female only
Enrollment
176 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
23
States / cities
Hot Springs, Arkansas • Washington D.C., District of Columbia • Ocoee, Florida + 19 more
Conditions
Acute Myeloid Leukemia
Interventions
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration, Cytarabine, Daunorubicin Hydrochloride, Echocardiography Test, Multigated Acquisition Scan, Venetoclax
Drug · Procedure
Lead sponsor
National Cancer Institute (NCI)
NIH
Eligibility
18 Years to 59 Years
Enrollment
153 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2027
U.S. locations
174
States / cities
Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 142 more
Conditions
HCC
Interventions
Electroporation Device, GNOS-PV02 + INO-9012 delivered by intradermal injection, followed by electroporation, INO-9012
Device · Biological
Lead sponsor
Geneos Therapeutics
Industry
Eligibility
18 Years and older
Enrollment
90 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2032
U.S. locations
7
States / cities
Atlanta, Georgia • New Orleans, Louisiana • Baltimore, Maryland + 4 more
Conditions
Schizophrenia
Interventions
Brenipatide, Placebo
Lead sponsor
Eli Lilly and Company
Industry
Eligibility
18 Years to 55 Years
Enrollment
450 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
32
States / cities
Little Rock, Arkansas • Bellflower, California • Garden Grove, California + 28 more
Conditions
Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasm, Triple Negative Breast Neoplasms, Uterine Cervical Neoplasms
Interventions
Itraconazole, Sofe-M, bevacizumab, carboplatin, pembrolizumab
Drug
Lead sponsor
Eli Lilly and Company
Industry
Eligibility
18 Years and older
Enrollment
575 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2029
U.S. locations
10
States / cities
Scottsdale, Arizona • La Jolla, California • Atlanta, Georgia + 6 more